Heart valve replacement: Which valve for which patient?

Current Cardiology Reports

Volumn 8, Issue 2, 2006, Pages 109-116

  Huh, Joseph ^a   Bakaeen, Faisal ^b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ADULT; AGED; AGING; AORTA VALVE PROSTHESIS; BJOERK SHILEY VALVE PROSTHESIS; BODY SIZE; CLINICAL TRIAL; COMORBIDITY; COW; DIALYSIS; ENDOCARDITIS; EQUIPMENT DESIGN; FLOW KINETICS; FOOD AND DRUG ADMINISTRATION; HANCOCK VALVE PROSTHESIS; HEART VALVE BIOPROSTHESIS; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INDIVIDUALIZATION; KIDNEY FAILURE; LIFE EXPECTANCY; LIFESTYLE; MEDICAL DECISION MAKING; NONHUMAN; PATIENT SELECTION; PHYSICIAN ATTITUDE; POSTOPERATIVE HEMORRHAGE; PREGNANCY; REOPERATION; REVIEW; RISK BENEFIT ANALYSIS; SAINT JUDE HEART VALVE PROSTHESIS; STARR EDWARDS VALVE PROSTHESIS; SURGEON; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; SWINE; THROMBOEMBOLISM; THROMBOGENICITY; TRICUSPID VALVE; VALVULAR HEART DISEASE;

AGE FACTORS; ANTICOAGULANTS; AORTIC VALVE; BIOPROSTHESIS; DECISION MAKING; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HUMANS; MITRAL VALVE; REOPERATION; RISK FACTORS;

EID: 33645344622     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-006-0021-2     Document Type: Review

References (64)

1. Bonow RO, Carabello B, de Leon AC Jr, et al.: ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 1998, 32:1486-1588.
2. Gott VL, Alejo DE, Cameron DE: Mechanical heart valves: 50 years of evolution. Ann Thorac Surg 2003, 76: S2230-2239.
3. van Gorp MJ, Steyerberg EW, van der Graaf Y: Decision guidelines for prophylactic replacement of Bjork-Shiley Convexo-Concave heart valves: impact on clinical practice. Circulation 2004, 109:2092-2096.
4. Butchart EG, Li HH, Payne N, et al.: Twenty years' experience with the Medtronic Hall valve. J Thorac Cardiovasc Surg 2001, 121:1090-1100.
5. Emery RW, Krogh CC, Arom KV, et al.: The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann Thorac Surg 2005, 79:776-783.
6. Niinanmi H, Aomi S, Tomioka H, et al.: A comparison of the in vivo performance of the 19-mm St. Jude Medical Hemodynamic Plus and 21-mm standard valve. Ann Thorac Surg 2002, 74:1120-1124.
7. Gelsomino s, Morocutti C, Da Col P, et al.: Early in vivo hemodynamic results after aortic valve replacement with the St. Jude Medical Regent mechanical heart valve in patients with pure aortic stenosis. J Card Surg 2003, 18:125-132.
8. Aagaard J, Tingleff J, Hansen CN, et al.: Twelve years' clinical experience with the CarboMedics prosthetic heart valve. J Heart Valve Dis 2001, 10:177-184.
9. Emery RW, Van Nooten GJ, Tesar PJ, et al.: The initial experience with the ATS Medical mechanical cardiac valve prosthesis. Ann Thorac Surg 2003, 75:444-452.
10. Moidl R, Simon P, Wolner E, et al.: The On-X prosthetic heart valve at five years. Ann Thorac Surg 2002, 74:S1312-1317.
11. Williams MA, Crause L, Van Riet S: A comparison of mechanical valve performance in a poorly anticoagulated community. J Card Surg 2004, 19:410-414.
12. Tominaga R, Kurisu K, Ochiai Y, et al.: A 10-year experience with the Carbomedics cardiac prosthesis. Ann Thorac Surg 2005, 79:784-789.
13. Stefanidids C, Nana AM, De Canniere D, et al.: 10-year experience with the ATS mechanical valve in the mitral position. Ann Thorac Surg 2005, 79:1934-1938.
14. Autschbach R, Walther T, Falk V, et al.: Prospectively randomized comparison of different mechanical aortic valves. Circulation 2000, 102(Suppl III):III-1-III-4.
15. Chambers J, Roxburgh J, Blauth C, et al.: A randomized comparison of the MCRI ON-X and Carbomedics Top Hat bileaflet mechanical replacement aortic valves: early postoperative hemodynamic function and clinical events. J Thorac Cardiovasc Surg 2005, 130:759-764.
16. Jamieson WRE, Burr LH, Miyagishima RT, et al.: Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years. J Thorac Cardiovasc Surg 2005, 130:994-1000.
17. Dellgren C, David TE, Raanani E, et al.: Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg 2002, 124:146-154.
18. Marchand MA, Aupart MR, Norton R, et al.: Fifteen-year experience with the mitral Carpentier Edwards PERI-MOUNT pericardial bioprosthesis. Ann Thorac Surg 2001, 71:S236-239.
19. Myken PS: Seventeen-year Experience with the St. Jude Medical Biocor Porcine bioprosthesis. J Heart Valve Dis 2005, 14:487-492.
20. Rizzoli G, Bottio T, Thiene G, et al.: Long-term durability of the Hancock II porcine bioprosthesis. J Thorac Cardiovasc Surg 2003, 126:66-74.
21. Cohn LH, Collins JJ, Rizzo RJ, et al.: Twenty-year follow-up of the Hancock Modified Orifice porcine aortic valve. Ann Thorac Surg 1998, 66:S30-S34.
22. Wong SP, Legget ME, Greaves SC, et al.: Early experience with the Mosaic bioprosthesis: A new generation of porcine valve. Ann Thorac Surg 2000, 69:1846-50.
23. Masters RG, Walley VM, Pipe AL, Keon WJ: Long-term experience with the Ionescu-Shiley pericardial valve. Ann Thorac Surg 1995, 60:S288-S291.
24. Totaro P, Degno N, Zaidi A, et al.: Carpentier-Edwards Perimount Magna bioprosthesis: a stented valve with stentless performance? J Thorac Cardiovasc Surg 2005, 130:1668-1674.
25. Silberman S, Shaheen J, Merin O, et al.: Exercise hemodynamics of aortic prostheses: Comparison between stentless bioprosthesis and mechanical valves. Ann Thorac Surg 2001, 72:1217-1221.
26. Westaby S, Horton M, Jin XY, et al.: Survival advantage of stentless aortic bioprostheses. Ann Thorac Surg 2000, 70:785-791.
27. Desai ND, Merin O, Cohen GN, et al.: Long-term results of aortic valve replacement with the St. Jude Toronto Stentless Porcine valve. Ann Thorac Surg 2004, 78:2076-2083.
28. Hammermeister K, Sethi GK, Henerson WG, et al.: Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affaires Randomized Trial. J Am Coll Cardiol 2000, 36:1152-1158.
29. Oxenham H, Bloomfield P, Wheatley DJ, et al.: Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart 2003, 89:715-721.
30. Banbury MK, Cosgrove DM III, White JA, et al.: Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2001, 72:753-757.
31. Milano A, Guglielmi C, De Carlo M, et al.: Valve-related complications in elderly patients with biological and mechanical aortic valves. Ann Thorac Surg 1998, 66:S82-87.
32. Bottio T, Caprili L, Casarotto D, et al.: Small aortic annulus: The hydrodynamic performances of 5 commercially available bileaflet mechanical valves. J Thorac Cardiovasc Surg 2004, 128:457-462.
33. Albes JM, Hartrumpf M, Rudolph V, et al.: Are mechanical valves with enhanced inner diameter advantageous in the small sized aortic annulus? Ann Thorac Surg 2003, 76:1564-1570.
34. Penta de Peppo A, Zeitani J, Nardi P, et al.: Small "functional" size after mechanical aortic valve replacement: no risk in young to middle-age patients. Ann Thorac Surg 2005, 1915-1920.
35. Cosgrove DM, Lytle BW, Gill CC, et al.: In vivo hemodynamic comparison of porcine and pericardial valves. J Thorac Cardiovasc Surg 1985, 89:358-368.
36. Khan SS, Siegel RJ, DeRobertis MA, et al.: Regression of hypertrophy after Carpentier-Edwards pericardial aortic valve replacement. Ann Thorac Surg 2000, 69:531-535.
37. Exercise hemodynamics of bovine versus porcine bioprostheses: A prospective randomized comparison of the Mosaic and Perimount aortic valves. J Thorac Cardiovasc Surg 2005, 129:1056-1063.
38. Seitelberger R, Bialy J, Gottardi R, et al.: Relation between size of prosthesis and valve gradient: Comparison of two aortic bioprosthesis. Eur J Cardiothorac Surg 2004, 25:358-363.
39. Botzenhardt F, Eichinger WB, Bleiziffer S, et al. Hemodynamic comparison of bioprostheses for complete supra-annular position in patients with small aortic annulus. J Am Coll Cardiol 2005, 45:2054-2060.
40. Vrandecic M, Fantini FA, Filho BG, et al.: Retrospective clinical analysis of stented vs. stentless porcine aortic bioprostheses. Eur J Cardiothorac Surg 2000, 18:46-53.
41. Akins CW, Buckley MJ, Daggett WM, et al.: risk of Reoperative valve replacement for failed mitral and aortic bioprostheses. Ann Thorac Surg 1998, 65:1545-1552.
42. Vogt PR, Brunner-LaRocca H, Sidler P, et al.: Reoperative surgery for degenerated aortic bioprostheses: predictors for emergency surgery and reoperative mortality. Eur J Cardiothorac Surg 2000, 17:134-139.
43. Potter DD, Sundt TM III, Zehr K, et al.: Operative risk of reoperative aortic valve replacement. J Thorac Cardiovasc Surg 2005, 129:94-103.
44. Jones JM, O'Kane H, Glandstone DJ, et al.: Repeat heart valve surgery: Risk factors for operative mortality. J Thorac Cardiovasc Surg 2001, 122:913-918.
45. Kirsch M, Nakashima K, Kubota S, et al.: The risk of reoperative heart valve procedures in octogenarian patients. J Heart Valve Dis 2004, 13:991-996.
46. Deeb GM, Smolens IA, Bolling SF, et al.: Reoperation for Freestyle stentless aortic valves. Semin Thorac Cardiovasc Surg 2001, 13:16-23.
47. Hering D, Piper C, Bergemann R, et al.: Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results from the German experience with low intensity anticoagulation study. Chest 2005, 127:53-59.
48. Salem DN, Stein PD, Al-Ahmad A, et al.: Antithrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004, 126:457S-482S.
49. Sundt TM, Zehr KJ, Dearani JA, et al.: Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? J Thorac Cardiovasc Surg 2005, 129:1024-1031.
50. Hylek EM: Complications of oral anticoagulant therapy (bleeding and nonbleeding: rates and risk factors). Semin Vasc Med 2003, 3:271-278.
51. Torn M, Bollen WL, van der Meer FJ, et al.: Risks of oral anticoagulant therapy with increasing age. Arch Intern Med 2005, 165:1527-1532.
52. Butchart EG, Payne N, Li HH, et al.: Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg 2002, 123:715-723.
53. Horstkotte D, Piper C: Improvement of oral anticoagulation therapy by INR self-management. J Heart Valve Dis 2004, 13:335-338.
54. Avila WS, Rossi EG, Grinberg M, Ramires JA: Influence of pregnancy after bioprosthetic valve replacement in young women: a prospective five-year study. J Heart Valve Dis 2002, 11:864-869.
55. Cotrufo M, De Feo M, De Santo LS, et al.: Risk of warfarin during pregnancy with mechanical valve prostheses. Obstet Gynecol 2002, 99:35-40.
56. Nassar AH, Hobeika EM, Abd Essamad HM, et al.: Pregnancy outcome in women with prosthetic heart valves. Am J Obstet Gynecol 2004, 191:1009-1013.
57. Al-Lawati AA, Venkitraman M, Al-Delaime T, Valliathu J: Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation. Eur J Cardiothorac Surg 2002, 22:223-7.
58. Chan WS, Anand S, Ginsberg JS: Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000, 160:191-196.
59. Lucke JC, Samy RN, Atkins BZ, et al.: Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. Ann Thorac Surg 1997, 64:129-133.
60. Kaplon RJ, Cosgrove DM III, Gillinov AM, et al.: Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann Thorac Surg 2000, 70:438-441.
61. Brinkman WT, Williams WH, Guyton RA, et al.: Valve replacement in patients on chronic renal dialysis: implications for valve prosthesis selection. Ann Thorac Surg 2002, 74:37-42.
62. Herzog CA, Ma JZ, Collins AJ: Long-term survival of dialysis patients in the United States with prosthetic heart valves: Should ACC/AHA practice guidelines on valve selection be modified? Circulation 2002, 105:1336-1341.
63. US Renal Data System, USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD; 2005.
64. Bauer F, Eltchaninoff H, Tron C, et al.: Acute improvement in global and regional left ventricular systolic function after percutaneous heart valve implantation in patients with symptomatic aortic stenosis. Circulation 2004, 110:1473-1476.